<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 15:32:47[mciao0828] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<trial  confidence="0.9511911446218017" wordnetid="105799212">
<header>
<title>Positron emission tomography</title>
<id>24032</id>
<revision>
<id>244325153</id>
<timestamp>2008-10-10T07:26:58Z</timestamp>
<contributor>
<username>Galoubet</username>
<id>7701610</id>
</contributor>
</revision>
<categories>
<category>Medical tests</category>
<category>Medical physics</category>
<category>Neuroimaging</category>
<category>Medical imaging</category>
<category>Nuclear medicine</category>
<category>Radiology</category>
</categories>
</header>
<bdy>

<image width="300px" src="ECAT-Exact-HR--PET-Scanner.jpg" type="thumb">
<caption>

Image of a typical positron emission tomography (PET) facility
</caption>
</image>

<b>Positron emission tomography</b> (<b>PET</b>) is a <link xlink:type="simple" xlink:href="../838/347838.xml">
nuclear medicine</link> <link xlink:type="simple" xlink:href="../714/234714.xml">
imaging</link> technique which produces a three-dimensional image or map of functional processes in the body. The system detects pairs of <link xlink:type="simple" xlink:href="../290/18616290.xml">
gamma ray</link>s emitted indirectly by a <link xlink:type="simple" xlink:href="../731/24731.xml">
positron</link>-emitting <link xlink:type="simple" xlink:href="../245/37245.xml">
radionuclide</link> (tracer), which is introduced into the body on a biologically active molecule. Images of tracer concentration in 3-dimensional space within the body are then reconstructed by computer analysis. In modern scanners, this reconstruction is often accomplished with the aid of a <link xlink:type="simple" xlink:href="../982/50982.xml">
CT X-ray scan</link> performed on the patient during the same session, in the same machine. <p>

If the biologically active molecule chosen for PET is <link xlink:type="simple" xlink:href="../796/3077796.xml">
FDG</link>, an analogue of glucose, the concentrations of tracer imaged then give tissue metabolic activity, in terms of regional glucose uptake. Although use of this tracer results in the most common type of PET scan, other tracer molecules are used in PET to image the tissue concentration of many other types of molecules of interest. </p>

<sec>
<st>
 Description </st>
<p>

<image width="150px" src="PET-detectorsystem_2.png" type="thumb">
<caption>

Schematic view of a detector block and ring of a PET scanner
</caption>
</image>
</p>

<ss1>
<st>
 Operation </st>
<p>

To conduct the scan, <b>a short-lived</b> <link xlink:type="simple" xlink:href="../767/197767.xml">
radioactive</link> tracer <link xlink:type="simple" xlink:href="../416/19600416.xml">
isotope</link>, is injected into the living subject (usually into <link xlink:type="simple" xlink:href="../997/3997.xml">
blood</link> circulation).  The tracer is chemically incorporated into a biologically active molecule, and eventually decays, emitting a <link xlink:type="simple" xlink:href="../731/24731.xml">
positron</link>.  There is a waiting period while the active molecule becomes concentrated in tissues of interest; then the research subject or patient is placed in the imaging scanner.  The molecule most commonly used for this purpose is <link xlink:type="simple" xlink:href="../796/3077796.xml">
fluorodeoxyglucose</link> (FDG), a sugar, for which the waiting period is typically an hour.
<image location="right" width="200px" src="PET-schema.png" type="thumb">
<caption>

Schema of a PET acquisition process
</caption>
</image>

As the radioisotope undergoes <link xlink:type="simple" xlink:href="../267/391267.xml">
positron emission</link> decay (also known as positive <link xlink:type="simple" xlink:href="../651/4651.xml">
beta decay</link>), it emits a positron, the <link xlink:type="simple" xlink:href="../317/1317.xml">
antimatter</link> counterpart of an <link xlink:type="simple" xlink:href="../476/9476.xml">
electron</link>. After travelling up to a few <link xlink:type="simple" xlink:href="../947/18947.xml">
millimeters</link> the positron encounters and annihilates with an electron, producing a pair of <link xlink:type="simple" xlink:href="../857/140857.xml">
annihilation</link> (<link xlink:type="simple" xlink:href="../290/18616290.xml">
gamma</link>) <link xlink:type="simple" xlink:href="../535/23535.xml">
photon</link>s moving in opposite directions. These are detected when they reach a <link xlink:type="simple" xlink:href="../323/454323.xml">
scintillator</link> material in the scanning device, creating a burst of light which is detected by <link xlink:type="simple" xlink:href="../215/177215.xml">
photomultiplier</link> tubes or silicon <link xlink:type="simple" xlink:href="../299/312299.xml">
avalanche photodiode</link>s (Si APD). The technique depends on simultaneous or coincident detection of the pair of photons; photons which do not arrive in pairs (i.e. within a timing window of few nanoseconds) are ignored.</p>

</ss1>
<ss1>
<st>
 Localization of the positron annihilation event </st>
<p>

The most significant fraction of electron-positron decays result in two 511 keV gamma photons being emitted at almost 180 degrees to each other; hence it is possible to localize their source along a straight line of coincidence (also called formally the <b>line of response</b> or <b>LOR</b>). In practice the LOR has a finite width as the emitted photons are not exactly 180 degrees apart. If the recovery time of detectors is in the picosecond range rather than the 10's of nanosecond range, it is possible to localize the event to a segment of a cord, whose length is determined by the detector timing resolution.  As the timing resolution improves, the signal-to-noise ratio (SNR) of the image will improve, requiring less events to achieve the same image quality.  This technology is not yet common, but it is available on some new systems <weblink xlink:type="simple" xlink:href="http://www.uphs.upenn.edu/news/News_Releases/jun06/PETCTITC.htm">
http://www.uphs.upenn.edu/news/News_Releases/jun06/PETCTITC.htm</weblink>.</p>

</ss1>
<ss1>
<st>
 Image reconstruction using coincidence statistics </st>
<p>

More commonly, a technique much like the reconstruction of <link xlink:type="simple" xlink:href="../982/50982.xml">
computed tomography</link> (CT) and <link xlink:type="simple" xlink:href="../499/291499.xml">
single photon emission computed tomography</link> (SPECT) data is used, although the <link xlink:type="simple" xlink:href="../495/8495.xml">
data set</link> collected in PET is much poorer than CT, so reconstruction techniques are more difficult (see <link xlink:type="simple" xlink:href="#xpointer(//*[./st=%22Image+reconstruction%22])">
Image reconstruction</link> of PET).</p>
<p>

Using statistics collected from tens-of-thousands of coincidence events, a set of simultaneous equations for the total activity of each parcel of tissue along many LORs can be solved by a number of techniques, and thus a map of radioactivities as a function of location for parcels or bits of tissue (also called <link xlink:type="simple" xlink:href="../573/222573.xml">
voxel</link>s), may be constructed and plotted. The resulting map shows the tissues in which the molecular probe has become concentrated, and can be interpreted by a nuclear medicine physician or <link xlink:type="simple" xlink:href="../623/152623.xml">
radiologist</link> in the context of the patient's diagnosis and treatment plan.</p>
<p>

<image location="left" width="200px" src="Complete_body_medical_imaging.JPG" type="thumb">
<caption>

A complete body PET / CT Fusion image
</caption>
</image>

<image location="right" width="200px" src="PET-MR2-Head-Keosys.JPG" type="thumb">
<caption>

A Brain PET / MRI Fusion image
</caption>
</image>

</p>
</ss1>
<ss1>
<st>
 Combination of PET with CT and MRI </st>
<p>

PET scans are increasingly read alongside CT or <link xlink:type="simple" xlink:href="../446/19446.xml">
magnetic resonance imaging</link> (MRI) scans, the combination (<link xlink:type="simple" xlink:href="../555/155555.xml">
"co-registration"</link>) giving both anatomic and metabolic information (i.e., what the structure is, and what it is doing biochemically). Because PET imaging is most useful in combination with anatomical imaging, such as CT, modern PET scanners are now available with integrated high-end multi-detector-row CT scanners. Because the two scans can be performed in immediate sequence during the same session, with the patient not changing position between the two types of scans, the two sets of images are more-precisely <link xlink:type="simple" xlink:href="../555/155555.xml">
registered</link>, so that areas of abnormality on the PET imaging can be more perfectly correlated with anatomy on the CT images. This is very useful in showing detailed views of moving organs or structures with higher amounts of anatomical variation, such as are more likely to occur outside the brain.</p>

</ss1>
<ss1>
<st>
 Radioisotopes </st>
<p>

<link xlink:type="simple" xlink:href="../245/37245.xml">
Radionuclide</link>s used in PET scanning are typically <link xlink:type="simple" xlink:href="../416/19600416.xml">
isotope</link>s with short <link xlink:type="simple" xlink:href="../606/13606.xml">
half lives</link> such as <link xlink:type="simple" xlink:href="../923/5276923.xml">
carbon-11</link> (~20 min), <link xlink:type="simple" xlink:href="../894/1072894.xml">
nitrogen-13</link> (~10 min), <link xlink:type="simple" xlink:href="../111/2527111.xml">
oxygen-15</link> (~2 min), and <link xlink:type="simple" xlink:href="../265/4226265.xml">
fluorine-18</link> (~110 min).  These radionuclides are incorporated either into compounds normally used by the body such as <link xlink:type="simple" xlink:href="../950/12950.xml">
glucose</link> (or glucose analogues), <link xlink:type="simple" xlink:href="../306/33306.xml">
water</link> or <link xlink:type="simple" xlink:href="../365/1365.xml">
ammonia</link>,  or into molecules that bind to receptors or other sites of drug action. Such labelled compounds are known as <link xlink:type="simple" xlink:href="../361/420361.xml">
radiotracer</link>s.  It is important to recognize that PET technology can be used to trace the biologic pathway of any compound in living humans (and many other species as well),  provided it can be radiolabeled with a PET isotope.  Thus the specific processes that can be probed with PET are virtually limitless, and radiotracers for new target molecules and processes are being synthesized all the time; as of this writing there are already dozens in clinical use and hundreds applied in research.  Due to the short half lives of most radioisotopes, the radiotracers must be produced using a  <link xlink:type="simple" xlink:href="../585/44585.xml">
cyclotron</link> and radiochemistry laboratory that are in close proximity to the PET imaging facility.  The half life of <link xlink:type="simple" xlink:href="../265/4226265.xml">
fluorine-18</link> is long enough such that <link xlink:type="simple" xlink:href="../265/4226265.xml">
fluorine-18</link>  labeled radiotracers can be manufactured commercially at an offsite location.</p>

</ss1>
<ss1>
<st>
 Limitations </st>
<p>

The minimization of radiation dose to the subject is an attractive feature of the use of short-lived radionuclides. Besides its established role as a diagnostic technique, PET has an expanding role as a method to  assess the response to therapy, in particular, cancer therapy,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref> where the risk to the patient from lack of knowledge about disease progress is much greater than the risk from the test radiation. </p>
<p>

Limitations to the widespread use of PET arise from the high costs of <link xlink:type="simple" xlink:href="../585/44585.xml">
cyclotrons</link> needed to produce the short-lived <link xlink:type="simple" xlink:href="../245/37245.xml">
radionuclide</link>s for PET scanning and the need for specially adapted on-site chemical synthesis apparatus to produce the radiopharmaceuticals. Few hospitals and universities are capable of maintaining such systems, and most clinical PET is supported by third-party suppliers of radiotracers which can supply many sites simultaneously. This limitation restricts clinical PET primarily to the use of tracers labelled with F-18, which has a half life of 110 minutes and can be transported a reasonable distance before use, or to <link xlink:type="simple" xlink:href="../868/4271868.xml">
rubidium-82</link>, which can be created in a portable generator and is used for <link xlink:type="simple" xlink:href="../364/502364.xml">
myocardial</link> <link xlink:type="simple" xlink:href="../863/1016863.xml">
perfusion</link> studies. Nevertheless, in recent years a few on-site cyclotrons with integrated shielding and hot labs have begun to accompany PET units to remote hospitals. The presence of the small on-site cyclotron promises to expand in the future as the cyclotrons shrink in response to the high cost of isotope transportation to remote PET machines <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>  </p>
<p>

Because the half-life of F-18 is about two hours, the prepared dose of a radiopharmaceutical bearing this radionuclide will undergo multiple half-lives of decay during the working day. This necessitates frequent recalibration of the remaining dose (determination of activity per unit volume) and careful planning with respect to patient scheduling.</p>

</ss1>
<ss1>
<st>
 Image reconstruction </st>
<p>

The raw data collected by a PET scanner are a list of 'coincidence events' representing near-simultaneous detection of annihilation photons by a pair of detectors. Each coincidence event represents a line in space connecting the two detectors along which the positron emission occurred.</p>
<p>

Coincidence events can be grouped into projections images, called <link xlink:type="simple" xlink:href="../663/4525663.xml">
sinogram</link>s. The sinograms are sorted by the angle of each view and tilt, the latter in 3D case images. The sinogram images are analogous to the projections captured by <link xlink:type="simple" xlink:href="../982/50982.xml">
computed tomography</link> (CT) scanners, and can be reconstructed in a similar way.  However, the statistics of the data is much worse than those obtained through transmission tomography. A normal PET data set has millions of counts for the whole acquisition, while the CT can reach a few billion counts. As such, PET data suffer from scatter and random events much more dramatically than CT data does.</p>
<p>

In practice, considerable pre-processing of the data is required - correction for random coincidences, estimation and subtraction of <link xlink:type="simple" xlink:href="../236/55236.xml">
scattered</link> photons, detector dead-time correction (after the detection of a photon, the detector must "cool down" again) and detector-sensitivity correction (for both inherent detector sensitivity and changes in sensitivity due to angle of incidence).</p>
<p>

<link>
Filtered back projection</link> (FBP) has been frequently used to reconstruct images from the projections. This algorithm has the advantage of being simple while having a low requirement for computing resources. However, <link xlink:type="simple" xlink:href="../700/41700.xml">
shot noise</link> in the raw data is prominent in the reconstructed images and areas of high tracer uptake tend to form streaks across the image.</p>
<p>

Iterative <link xlink:type="simple" xlink:href="../752/470752.xml">
expectation-maximization algorithm</link>s are now the preferred method of reconstruction. The advantage is a better noise profile and resistance to the streak artifacts common with FBP, but the disadvantage is higher computer resource requirements.</p>
<p>

<b>Attenuation correction</b>: As different LORs must traverse different thicknesses of tissue, the <link xlink:type="simple" xlink:href="../535/23535.xml">
photon</link>s are attenuated differentially. The result is that structures deep in the body are reconstructed as having falsely low tracer uptake. Contemporary scanners can estimate attenuation using integrated <link xlink:type="simple" xlink:href="../197/34197.xml">
x-ray</link> CT equipment, however earlier equipment offered a crude form of CT using a <link xlink:type="simple" xlink:href="../290/18616290.xml">
gamma ray</link> (<link xlink:type="simple" xlink:href="../731/24731.xml">
positron</link> emitting) source and the PET detectors.</p>
<p>

While attenuation corrected images are generally more faithful representations, the correction process is itself susceptible to significant artifacts. As a result, both corrected and uncorrected images are always reconstructed and read together.</p>
<p>

<b>2D/3D reconstruction</b>: Early PET scanners had only a single ring of detectors, hence the acquisition of data and subsequent reconstruction was restricted to a single transverse plane. More modern scanners now include multiple rings, essentially forming a cylinder of detectors.</p>
<p>

There are two approaches to reconstructing data from such a scanner: 1) treat each ring as a separate entity, so that only coincidences within a ring are detected, the image from each ring can then be reconstructed individually (2D reconstruction), or 2) allow coincidences to be detected between rings as well as within rings, then reconstruct the entire volume together (3D).</p>
<p>

3D techniques have better sensitivity (because more coincidences are detected and used) and therefore less noise, but are more sensitive to the effects of scatter and random coincidences, as well as requiring correspondingly greater computer resources.  The advent of sub-nanosecond timing resolution detectors affords better random coincidence rejection, thus favoring 3D image reconstruction.</p>

</ss1>
</sec>
<sec>
<st>
 History </st>
<p>

The concept of emission and transmission tomography was introduced by <link>
David Kuhl</link> and Roy Edwards in the late 1950s. Their work later led to the design and construction of several tomographic instruments at the <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../793/31793.xml">
University of Pennsylvania</link></university>
. Tomographic imaging techniques were further developed by <link xlink:type="simple" xlink:href="../174/6467174.xml">
Michel Ter-Pogossian</link>, <link xlink:type="simple" xlink:href="../957/12632957.xml">
Michael E. Phelps</link> and others at the <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../402/3016402.xml">
Washington University School of Medicine</link></university>
.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref></p>
<p>

Work by Gordon Brownell, Charles Burnham and their associates at the <hospital wordnetid="103540595" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../900/1149900.xml">
Massachusetts General Hospital</link></hospital>
 beginning in the 1950s contributed significantly to the development of PET technology and included the first demonstration of annihilation radiation for medical imaging<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref>. Their innovations, including the use of light pipes, and volumetric analysis have been important in the deployment of PET imaging. </p>
<p>

In the 1970s, Tatsuo Ido at the Brookhaven National Laboratory was the first to describe the synthesis of 18F-<link xlink:type="simple" xlink:href="../796/3077796.xml">
FDG</link>, the most commonly used PET scanning isotope carrier. The compound was first administered to two normal human volunteers by <link xlink:type="simple" xlink:href="../914/14152914.xml">
Abass Alavi</link> in August 1976 at the University of Pennsylvania. Brain images obtained with an ordinary (non-PET) nuclear scanner demonstrated the concentration of FDG in that organ. Later, the substance was used in dedicated positron tomographic scanners, to yield the modern procedure.</p>

</sec>
<sec>
<st>
 Applications </st>
<p>

<image location="right" width="150px" src="PET-MIPS-anim.gif" type="thumb">
</image>
 
PET is both a medical and research tool. It is used heavily in clinical <link xlink:type="simple" xlink:href="../580/66580.xml">
oncology</link> (<link xlink:type="simple" xlink:href="../623/152623.xml">
medical imaging</link> of <link xlink:type="simple" xlink:href="../214/31214.xml">
tumor</link>s and the search for <link xlink:type="simple" xlink:href="../509/152509.xml">
metastases</link>), and for clinical diagnosis of certain diffuse brain diseases such as those causing various types of dementias.  PET is also an important research tool to map normal human brain and heart function.</p>
<p>

PET is also used in pre-clinical studies using animals, where it allows repeated investigations into the same subjects. This is particularly valuable in cancer research, as it results in an increase in the statistical quality of the data (subjects can act as their own control) and substantially reduces the numbers of animals required for a given study. </p>
<p>

Alternative methods of scanning include <link xlink:type="simple" xlink:href="../197/34197.xml">
x-ray</link> <link xlink:type="simple" xlink:href="../982/50982.xml">
computed tomography</link> (CT), <link xlink:type="simple" xlink:href="../446/19446.xml">
magnetic resonance imaging</link> (MRI) and <link xlink:type="simple" xlink:href="../722/226722.xml">
functional magnetic resonance imaging</link> (fMRI), <link xlink:type="simple" xlink:href="../780/31780.xml">
ultrasound</link> and <link xlink:type="simple" xlink:href="../499/291499.xml">
single photon emission computed tomography</link> (SPECT). </p>
<p>

While some imaging scans such as <link xlink:type="simple" xlink:href="../982/50982.xml">
CT</link> and <link xlink:type="simple" xlink:href="../450/19450.xml">
MRI</link> isolate organic anatomic changes in the body, PET and SPECT are capable of detecting areas of <link xlink:type="simple" xlink:href="../200/19200.xml">
molecular biology</link> detail (even prior to anatomic change). PET scanning does this using radiolabelled molecular probes that have different rates of uptake depending on the type and function of tissue involved. Changing of regional blood flow in various anatomic structures (as a measure of the injected positron emitter) can be visualized and relatively quantified with a PET scan.</p>
<p>

PET imaging is best performed using a dedicated PET scanner. However, it is possible to acquire PET images using a conventional dual-head <link xlink:type="simple" xlink:href="../494/862494.xml">
gamma camera</link> fitted with a coincidence detector. The quality of gamma-camera PET is considerably lower, and acquisition is slower. However, for institutions with low demand for PET, this may allow on-site imaging, instead of referring patients to another center, or relying on a visit by a mobile scanner.</p>
<p>

PET is a valuable technique for some diseases and disorders, because  it is possible to target the radio-chemicals used for particular bodily functions.</p>
<p>

<list>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../580/66580.xml">
Oncology</link>: PET scanning with the tracer <link xlink:type="simple" xlink:href="../265/4226265.xml">
fluorine-18</link> (F-18) <link xlink:type="simple" xlink:href="../796/3077796.xml">
fluorodeoxyglucose</link> (FDG), called FDG-PET, is widely used in clinical <link xlink:type="simple" xlink:href="../580/66580.xml">
oncology</link>.  This tracer is a <link xlink:type="simple" xlink:href="../950/12950.xml">
glucose</link> <link xlink:type="simple" xlink:href="../890/3088890.xml">
analog</link> that is taken up by glucose-using cells and phosphorylated by <link xlink:type="simple" xlink:href="../958/152958.xml">
hexokinase</link> (whose <link xlink:type="simple" xlink:href="../588/19588.xml">
mitochondrial</link> form is greatly elevated in rapidly-growing <link xlink:type="simple" xlink:href="../900/549900.xml">
malignant</link> tumours). A typical dose of FDG used in an oncological scan is 200-400 M<unit_of_measurement wordnetid="113583724" confidence="0.8">
<definite_quantity wordnetid="113576101" confidence="0.8">
<link xlink:type="simple" xlink:href="../835/155835.xml">
Bq</link></definite_quantity>
</unit_of_measurement>
 for an adult human. Because the <link xlink:type="simple" xlink:href="../303/22303.xml">
oxygen</link> atom which is replaced by F-18 to generate FDG is required for the next step in glucose <link xlink:type="simple" xlink:href="../374/20374.xml">
metabolism</link> in all cells, no further reactions occur in FDG. Furthermore, most tissues (with the notable exception of liver and kidneys) cannot remove the <link xlink:type="simple" xlink:href="../690/23690.xml">
phosphate</link> added by <link xlink:type="simple" xlink:href="../958/152958.xml">
hexokinase</link>. This means that FDG is trapped in any cell which takes it up, until it decays, since <link xlink:type="simple" xlink:href="../894/58894.xml">
phosphorylated</link> sugars, due to their ionic charge, cannot exit from the cell. This results in intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and most cancers.  As a result, FDG-PET can be used for diagnosis, staging, and monitoring treatment of cancers, particularly in <link xlink:type="simple" xlink:href="../971/563971.xml">
Hodgkin's disease</link>, non Hodgkin's <link xlink:type="simple" xlink:href="../422/71422.xml">
lymphoma</link>, and <link xlink:type="simple" xlink:href="../450/18450.xml">
lung cancer</link>. Many other types of solid tumors will be found to be very highly labeled on a case-by-case basis-- a fact which becomes especially useful in searching for tumor <link xlink:type="simple" xlink:href="../509/152509.xml">
metastasis</link>, or for recurrence after a known highly-active primary tumor is removed. Because individual PET scans are more expensive than "conventional" imaging with <link xlink:type="simple" xlink:href="../982/50982.xml">
computed tomography</link> (CT) and <link xlink:type="simple" xlink:href="../446/19446.xml">
magnetic resonance imaging</link> (MRI), expansion of FDG-PET in cost-constrained health services will depend on proper <link>
health technology assessment</link>; this problem is a difficult one because structural and functional imaging often cannot be directly compared, as they provide different information. Oncology scans using FDG make up over 90% of all PET scans in current practice. </entry>
<entry level="1" type="number">

 <image location="right" width="200px" src="PET-image.jpg" type="thumb">
<caption>

PET scan of the human brain.
</caption>
</image>
<link xlink:type="simple" xlink:href="../226/21226.xml">
Neurology</link>: PET <link xlink:type="simple" xlink:href="../219/3557219.xml">
neuroimaging</link> is based on an assumption that areas of high radioactivity are associated with brain activity. What is actually measured indirectly is the flow of blood to different parts of the brain, which is generally believed to be correlated, and has been measured using the tracer <link xlink:type="simple" xlink:href="../303/22303.xml">
oxygen</link>-15. However, because of its 2-minute half-life O-15 must be piped directly from a medical <link xlink:type="simple" xlink:href="../585/44585.xml">
cyclotron</link> for such uses, and this is difficult. In practice, since the brain is normally a rapid user of glucose, and since brain pathologies such as <link xlink:type="simple" xlink:href="../017/18914017.xml">
Alzheimer's disease</link> greatly decrease brain metabolism of both glucose and oxygen in tandem, standard FDG-PET of the brain, which measures regional glucose use, may also be successfully used to differentiate Alzheimer's disease from other dementing processes, and also to make early diagnosis of Alzheimer's disease. The advantage of FDG-PET for these uses is its much wider availability.  PET imaging with FDG can also be used for localization of seizure focus: A seizure focus will appear as hypometabolic during an interictal scan. Several <link xlink:type="simple" xlink:href="../361/420361.xml">
radiotracer</link>s (i.e. <link xlink:type="simple" xlink:href="../594/517594.xml">
radioligand</link>s) have been developed for PET that are <link xlink:type="simple" xlink:href="../422/2202422.xml">
ligands</link> for specific <link xlink:type="simple" xlink:href="../480/569480.xml">
neuroreceptor</link> subtypes such as [11C] <link xlink:type="simple" xlink:href="../645/3755645.xml">
raclopride</link> and [18F] fallypride for <link xlink:type="simple" xlink:href="../548/48548.xml">
dopamine</link> D2/D3 receptors, [11C]McN 5652 and [11C]<link xlink:type="simple" xlink:href="../722/15378722.xml">
DASB</link> for <link xlink:type="simple" xlink:href="../669/480669.xml">
serotonin transporter</link>s, or enzyme substrates (e.g. 6-<link>
FDOPA</link> for the AADC enzyme).  These agents permit the visualization of  neuroreceptor pools in the context of a plurality of neuropsychiatric and neurologic illnesses. A novel probe developed at the University of Pittsburgh termed PIB (Pittsburgh Compound-B) permits the visualization of <link xlink:type="simple" xlink:href="../724/396724.xml">
amyloid</link> plaques in the brains of Alzheimer's patients. This technology could assist clinicians in making a positive clinical diagnosis of AD pre-mortem and aid in the development of novel anti-amyloid therapies. </entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../421/5421.xml">
Cardiology</link>, <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link> and vascular disease study: In clinical <link xlink:type="simple" xlink:href="../421/5421.xml">
cardiology</link>, FDG-PET can identify so-called "hibernating <link xlink:type="simple" xlink:href="../364/502364.xml">
myocardium</link>", but its <link xlink:type="simple" xlink:href="../128/265128.xml">
cost-effectiveness</link> in this role versus <link xlink:type="simple" xlink:href="../499/291499.xml">
SPECT</link> is unclear. Recently, a role has been suggested for FDG-PET imaging of <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link> to detect patients at risk of <link xlink:type="simple" xlink:href="../404/625404.xml">
stroke</link> <weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/content/abstract/105/23/2708">
http://circ.ahajournals.org/cgi/content/abstract/105/23/2708</weblink>.</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../292/288292.xml">
Neuropsychology</link> / <link xlink:type="simple" xlink:href="../326/50326.xml">
Cognitive neuroscience</link>: To examine links between specific psychological processes or disorders and brain activity.</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../869/18973869.xml">
Psychiatry</link>:  Numerous compounds that bind selectively to neuroreceptors of interest in biological psychiatry have been radiolabeled with C-11 or F-18.  <link xlink:type="simple" xlink:href="../594/517594.xml">
Radioligand</link>s that bind to <link xlink:type="simple" xlink:href="../439/737439.xml">
dopamine receptor</link>s (D1,D2, reuptake transporter), <link xlink:type="simple" xlink:href="../392/736392.xml">
serotonin receptor</link>s (5HT1A, 5HT2A, reuptake transporter) <link xlink:type="simple" xlink:href="../407/736407.xml">
opioid receptor</link>s (mu) and other sites have been used successfully in studies with human subjects.  Studies have been performed examining the state of these receptors in patients compared to healthy controls in <link xlink:type="simple" xlink:href="../790/27790.xml">
schizophrenia</link>, <link xlink:type="simple" xlink:href="../038/256038.xml">
substance abuse</link>, <link xlink:type="simple" xlink:href="../316/52316.xml">
mood disorder</link>s and other psychiatric conditions.</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../354/24354.xml">
Pharmacology</link>: In pre-clinical trials, it is possible to <link xlink:type="simple" xlink:href="../307/1652307.xml">
radiolabel</link> a new drug and inject it into animals. The uptake of the drug, the tissues in which it concentrates, and its eventual elimination, can be monitored far more quickly and cost effectively than the older technique of killing and dissecting the animals to discover the same information. A miniature PET tomograph has been constructed that is small enough for a fully conscious and mobile rat to wear on its head while walking around <weblink xlink:type="simple" xlink:href="http://www.chemistry.bnl.gov/ratcap/gallery.html">
http://www.chemistry.bnl.gov/ratcap/gallery.html</weblink>. This RatCAP (Rat Conscious Animal PET) allows animals to be scanned without the confounding effects of <link xlink:type="simple" xlink:href="../561/56561.xml">
anesthesia</link>. PET scanners for rats and non-human primates are marketed for this purpose. The technique is still generally too expensive for the veterinary medicine market, however, so very few pet PET scans are done. Drug occupancy at the purported site of action can also be inferred indirectly by competition studies between unlabeled drug and radiolabeled compounds known apriori to bind with specificity to the site.</entry>
</list>
</p>

</sec>
<sec>
<st>
 Safety </st>

<p>

PET scanning is non-invasive, but it does involve exposure to <link xlink:type="simple" xlink:href="../522/202522.xml">
ionizing radiation</link>.  The total dose of radiation is small, however, usually around 7 m<unit_of_measurement wordnetid="113583724" confidence="0.8">
<definite_quantity wordnetid="113576101" confidence="0.8">
<link xlink:type="simple" xlink:href="../823/155823.xml">
Sv</link></definite_quantity>
</unit_of_measurement>
.  This can be compared to 2.2 mSv average annual <link xlink:type="simple" xlink:href="../882/4882.xml">
background radiation</link> in the <autocracy wordnetid="108361001" confidence="0.8">
<system wordnetid="108435388" confidence="0.8">
<social_group wordnetid="107950920" confidence="0.8">
<political_orientation wordnetid="106212839" confidence="0.8">
<monarchy wordnetid="108363812" confidence="0.8">
<state wordnetid="108168978" confidence="0.8">
<political_unit wordnetid="108359949" confidence="0.8">
<political_system wordnetid="108367880" confidence="0.8">
<economy wordnetid="108366753" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<democracy wordnetid="106217103" confidence="0.8">
<link xlink:type="simple" xlink:href="../717/31717.xml">
UK</link></democracy>
</group>
</economy>
</political_system>
</political_unit>
</state>
</monarchy>
</political_orientation>
</social_group>
</system>
</autocracy>
, 0.02 mSv for a chest x-ray, up to 8 mSv for a CT scan of the chest, 2-6 mSv per annum for aircrew (data from UK <body wordnetid="105216365" confidence="0.8">
<natural_object wordnetid="100019128" confidence="0.8">
<link xlink:type="simple" xlink:href="../241/1257241.xml">
National Radiological Protection Board</link></natural_object>
</body>
).  Patients with small children may be advised to limit proximity to them for several hours following the completion of the test.</p>

</sec>
<sec>
<st>
 See also </st>
<p>

<list>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../260/1106260.xml">
Diffuse optical imaging</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../305/2715305.xml">
Hot cell</link> (Equipment used to produce the radiopharmaceuticals used in PET)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../142/3457142.xml">
Molecular Imaging</link></entry>
</list>
</p>

</sec>
<sec>
<st>
References</st>


<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal">Young H, Baum R, Cremerius U, et al.&#32;(1999).&#32;"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations.". <it>European Journal of Cancer</it>&#32;<b>35</b>&#32;(13): 1773–1782. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0959-8049%2899%2900229-4">
10.1016/S0959-8049(99)00229-4</weblink>.</cite>&nbsp;</entry>
<entry id="2">
<weblink xlink:type="simple" xlink:href="http://www.medicalimagingmag.com/issues/articles/2003-07_05.asp">
Technology | July 2003: Trends in MRI | Medical Imaging</weblink></entry>
<entry id="3">
 <cite style="font-style:normal">Ter-Pogossian, M.M.; M.E. Phelps, E.J. Hoffman&#32;(1975).&#32;"<weblink xlink:type="simple" xlink:href="http://www.osti.gov/energycitations/product.biblio.jsp?osti_id=4251398">
A positron-emission transaxial tomograph for nuclear imaging (PET)</weblink>". <it><link>
Radiology</link></it>&#32;<b>114</b>&#32;(1): 89-98.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Phelps, M.E.; E.J. Hoffman, N.A. Mullani, M.M. Ter-Pogossian&#32;(1975).&#32;"<weblink xlink:type="simple" xlink:href="http://jnm.snmjournals.org/cgi/content/abstract/16/3/210">
Application of annihilation coincidence detection to transaxial reconstruction tomography</weblink>". <it><link>
Journal of Nuclear Medicine</link></it>&#32;<b>16</b>&#32;(3): 210-224. PMID 1113170.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Sweet, W.H.; G.L. Brownell&#32;(1953).&#32;"Localization of brain tumors with positron emitters". <it><link xlink:type="simple" xlink:href="../285/21285.xml">
Nucleonics</link></it>&#32;<b>11</b>: 40-45.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
<sec>
<st>
 Further reading </st>
<p>

<list>
<entry level="1" type="bullet">

  <cite style="font-style:normal">Bustamante E. and Pedersen P.L.&#32;(1977).&#32;"High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase.". <it>Proceedings of the National Academy of Sciences USA</it>&#32;<b>74</b>&#32;(9): 3735–3739. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1073%2Fpnas.74.9.3735">
10.1073/pnas.74.9.3735</weblink>.</cite>&nbsp;</entry>
<entry level="1" type="bullet">

  <cite style="font-style:normal">Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, and Langstrom B.&#32;(2004).&#32;"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.". <it>Annals of Neurology</it>&#32;<b>55</b>&#32;(3): 306–319. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fana.20009">
10.1002/ana.20009</weblink>.</cite>&nbsp;</entry>
</list>
</p>


</sec>
<sec>
<st>
 External links </st>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://rad.usuhs.edu/medpix/master.php3?mode=image_finder&amp;action=search&amp;srchstr=&amp;srch_type=all&amp;labels=&amp;details=2&amp;no_filter=2&amp;plane_id=&amp;capt_id=-4&amp;filter_m=modality&amp;filter_o=&amp;acr_pre=&amp;filter_p=&amp;acr_post=#top">
PET Images</weblink> Search MedPix(r)</entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.natureprotocols.com/2006/12/21/seeing_is_believing_in_vivo_fu_1.php">
Seeing is believing: In vivo functional real-time imaging of transplanted islets using positron emission tomography (PET)(a protocol)</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://nuccast.com">
The nuclear medicine and molecular medicine podcast</weblink> - Podcast</entry>
</list>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";" class="navbox-title">
<link xlink:type="simple" xlink:href="../830/97830.xml">
Nuclear technology</link></header>
</row>
<row style="height:2px;">

</row>
<row>
<col style=";;" class="navbox-group">
Science</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../285/21285.xml">
Physics</link>&nbsp;·  <link xlink:type="simple" xlink:href="../054/22054.xml">
Fission</link>&nbsp;·  <link xlink:type="simple" xlink:href="../544/21544.xml">
Fusion</link>&nbsp;·  <link xlink:type="simple" xlink:href="../856/25856.xml">
Radiation</link> (<link xlink:type="simple" xlink:href="../522/202522.xml">
ionizing</link>)&nbsp;·  <link xlink:type="simple" xlink:href="../411/54411.xml">
Nucleus</link>&nbsp;·  <issue wordnetid="105814650" confidence="0.8">
<link xlink:type="simple" xlink:href="../539/4222539.xml">
Safety</link></issue>
&nbsp;·  <link xlink:type="simple" xlink:href="../001/242001.xml">
Chemistry</link>&nbsp;·  <link xlink:type="simple" xlink:href="../207/37207.xml">
Engineering</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../416/2046416.xml">
Fuels</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../865/2197865.xml">
Fertile material</link>&nbsp;·  <link xlink:type="simple" xlink:href="../044/30044.xml">
Thorium</link>&nbsp;·  <link xlink:type="simple" xlink:href="../743/31743.xml">
Uranium</link> (<substance wordnetid="100019613" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../555/37555.xml">
enriched</link></material>
</part>
</substance>
&nbsp;&amp;bull;  <controversy wordnetid="107183151" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<dispute wordnetid="107181935" confidence="0.8">
<disagreement wordnetid="107180787" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<speech_act wordnetid="107160883" confidence="0.8">
<link xlink:type="simple" xlink:href="../514/37514.xml">
depleted</link></speech_act>
</psychological_feature>
</act>
</disagreement>
</dispute>
</event>
</controversy>
)&nbsp;·  <link xlink:type="simple" xlink:href="../684/7987684.xml">
Plutonium</link>&nbsp;·  <link xlink:type="simple" xlink:href="../524/8524.xml">
Deuterium</link>&nbsp;·  <link xlink:type="simple" xlink:href="../306/31306.xml">
Tritium</link>&nbsp;·  <link xlink:type="simple" xlink:href="../197/37197.xml">
Isotope separation</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../153/22153.xml">
Power</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;" class="navbox-list navbox-odd">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../151/22151.xml">
Reactor technology</link></kind>
</type>
</category>
</concept>
</idea>
&nbsp;·  <link xlink:type="simple" xlink:href="../742/10838742.xml">
Economics</link>&nbsp;·  <link xlink:type="simple" xlink:href="../572/496572.xml">
Propulsion</link> (<link xlink:type="simple" xlink:href="../842/37842.xml">
rocket</link>)&nbsp;·  <link xlink:type="simple" xlink:href="../017/55017.xml">
Fusion</link>&nbsp;·  <artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<apparatus wordnetid="102727825" confidence="0.8">
<generator wordnetid="103434188" confidence="0.8">
<equipment wordnetid="103294048" confidence="0.8">
<link xlink:type="simple" xlink:href="../485/211485.xml">
Isotope thermoelectric (RTG)</link></equipment>
</generator>
</apparatus>
</instrumentality>
</artifact>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../151/22151.xml">
Reactor
types</link> by<link xlink:type="simple" xlink:href="../896/188896.xml">
moderator</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;padding:0;" class="navbox-list navbox-even">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../884/1212884.xml">
Water</link></kind>
</type>
</category>
</concept>
</idea>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../350/143350.xml">
Pressurized (PWR)</link>&nbsp;·  <link xlink:type="simple" xlink:href="../351/143351.xml">
Boiling (BWR)</link>&nbsp;·    <reactor wordnetid="104057846" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<link xlink:type="simple" xlink:href="../134/2941134.xml">
Supercritical (SCWR)</link></device>
</electrical_device>
</instrumentality>
</artifact>
</reactor>
&nbsp;·    <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../558/3488558.xml">
Heavy</link></kind>
</type>
</category>
</concept>
</idea>
 (<link xlink:type="simple" xlink:href="../475/7475.xml">
CANDU</link>)&nbsp;· <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../828/3056828.xml">
PHWR</link></kind>
</type>
</category>
</concept>
</idea>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../577/6231577.xml">
Carbon</link></kind>
</type>
</category>
</concept>
</idea>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../354/143354.xml">
Pebble bed (PBMR)</link></kind>
</type>
</category>
</concept>
</idea>
&nbsp;·  <reactor wordnetid="104057846" confidence="0.8">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../769/2965769.xml">
Very high temperature (VHTR)</link></kind>
</type>
</device>
</electrical_device>
</instrumentality>
</artifact>
</category>
</concept>
</idea>
</reactor>
&nbsp;·   <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../088/213088.xml">
RBMK</link></kind>
</type>
</category>
</concept>
</idea>
&nbsp;·     <reactor wordnetid="104057846" confidence="0.8">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../354/394354.xml">
Magnox</link></kind>
</type>
</device>
</electrical_device>
</instrumentality>
</artifact>
</category>
</concept>
</idea>
</reactor>
&nbsp;·  <reactor wordnetid="104057846" confidence="0.8">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../352/143352.xml">
AGR</link></kind>
</type>
</device>
</electrical_device>
</instrumentality>
</artifact>
</category>
</concept>
</idea>
</reactor>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../561/17561.xml">
Li</link> / <link xlink:type="simple" xlink:href="../378/3378.xml">
Be</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<reactor wordnetid="104057846" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<link xlink:type="simple" xlink:href="../031/1584031.xml">
Molten salt (MSR)</link></device>
</electrical_device>
</instrumentality>
</artifact>
</reactor>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../488/888488.xml">
None(Fast)</link></kind>
</type>
</category>
</concept>
</idea>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../035/194035.xml">
Breeder (FBR)</link></kind>
</type>
</category>
</concept>
</idea>
&nbsp;·   <reactor wordnetid="104057846" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<link xlink:type="simple" xlink:href="../787/4608787.xml">
Liquid-metal-cooled (LMFR)</link></device>
</electrical_device>
</instrumentality>
</artifact>
</reactor>
&nbsp;·  <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../401/1429401.xml">
Integral (IFR)</link></kind>
</type>
</category>
</concept>
</idea>
&nbsp;·    <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../451/1228451.xml">
SSTAR</link></kind>
</type>
</category>
</concept>
</idea>
 <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../233/2964233.xml#xpointer(//*[./st=%22Fast+reactors%22])">
Generation IV</link></kind>
</type>
</category>
</concept>
</idea>
 (<reactor wordnetid="104057846" confidence="0.8">
<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../110/2966110.xml">
Gas (GFR)</link></kind>
</type>
</device>
</electrical_device>
</instrumentality>
</artifact>
</category>
</concept>
</idea>
</reactor>
&nbsp;·    <reactor wordnetid="104057846" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<link xlink:type="simple" xlink:href="../606/2966606.xml">
Lead (LFR)</link></device>
</electrical_device>
</instrumentality>
</artifact>
</reactor>
&nbsp;·  <reactor wordnetid="104057846" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<electrical_device wordnetid="103269401" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<link xlink:type="simple" xlink:href="../489/3122489.xml">
Sodium (SFR)</link></device>
</electrical_device>
</instrumentality>
</artifact>
</reactor>
)</col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../838/347838.xml">
Medical</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;padding:0;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../714/234714.xml">
Imaging</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../032/24032.xml">
Positron emission (PET)</link>&nbsp;·  <link xlink:type="simple" xlink:href="../499/291499.xml">
Single photon emission (SPECT)</link>&nbsp;·  <artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<detector wordnetid="103180969" confidence="0.8">
<link xlink:type="simple" xlink:href="../494/862494.xml">
Gamma camera</link></detector>
</device>
</instrumentality>
</artifact>
&nbsp;·  <link xlink:type="simple" xlink:href="../197/34197.xml">
X-rays</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;;" class="navbox-group">
Therapy</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../350/26350.xml">
Radiation therapy</link>&nbsp;·  <link xlink:type="simple" xlink:href="../556/10967556.xml">
Tomotherapy</link>&nbsp;·  <work wordnetid="100575741" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../549/1164549.xml">
Proton</link></activity>
</psychological_feature>
</act>
</care>
</event>
</treatment>
</work>
&nbsp;·  <link xlink:type="simple" xlink:href="../538/273538.xml">
Brachytherapy</link>&nbsp;·  <link xlink:type="simple" xlink:href="../626/8697626.xml">
Boron neutron capture (BNCT)</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../785/21785.xml">
Arms</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;padding:0;" class="navbox-list navbox-even">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;width:5.0em; font-weight:normal;;" class="navbox-group">
Topics</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em; width:auto;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../883/242883.xml">
History</link>&nbsp;·  <link xlink:type="simple" xlink:href="../911/172911.xml">
Design</link>&nbsp;·  <link xlink:type="simple" xlink:href="../880/36880.xml">
War</link>&nbsp;·  <artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<weapon_of_mass_destruction wordnetid="104565963" confidence="0.8">
<weapon wordnetid="104565375" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<instrument wordnetid="103574816" confidence="0.8">
<nuclear_weapon wordnetid="103834604" confidence="0.8">
<link xlink:type="simple" xlink:href="../704/585704.xml">
Race</link></nuclear_weapon>
</instrument>
</device>
</weapon>
</weapon_of_mass_destruction>
</instrumentality>
</artifact>
&nbsp;·  <link xlink:type="simple" xlink:href="../587/4380587.xml">
Explosion</link> (<link xlink:type="simple" xlink:href="../601/244601.xml">
effects</link>)&nbsp;·  <process wordnetid="105701363" confidence="0.8">
<inquiry wordnetid="105797597" confidence="0.8">
<thinking wordnetid="105770926" confidence="0.8">
<problem_solving wordnetid="105796750" confidence="0.8">
<experiment wordnetid="105798043" confidence="0.8">
<trial wordnetid="105799212" confidence="0.8">
<higher_cognitive_process wordnetid="105770664" confidence="0.8">
<link xlink:type="simple" xlink:href="../775/337775.xml">
Testing</link></higher_cognitive_process>
</trial>
</experiment>
</problem_solving>
</thinking>
</inquiry>
</process>
 (<process wordnetid="105701363" confidence="0.8">
<inquiry wordnetid="105797597" confidence="0.8">
<thinking wordnetid="105770926" confidence="0.8">
<problem_solving wordnetid="105796750" confidence="0.8">
<experiment wordnetid="105798043" confidence="0.8">
<trial wordnetid="105799212" confidence="0.8">
<higher_cognitive_process wordnetid="105770664" confidence="0.8">
<link xlink:type="simple" xlink:href="../891/7459891.xml">
underground</link></higher_cognitive_process>
</trial>
</experiment>
</problem_solving>
</thinking>
</inquiry>
</process>
)&nbsp;·  <link xlink:type="simple" xlink:href="../324/3247324.xml">
Delivery</link>&nbsp;·  <link xlink:type="simple" xlink:href="../158/22158.xml">
Proliferation</link>&nbsp;·  <link xlink:type="simple" xlink:href="../631/3145631.xml">
Yield</link> (<unit_of_measurement wordnetid="113583724" confidence="0.8">
<definite_quantity wordnetid="113576101" confidence="0.8">
<link xlink:type="simple" xlink:href="../328/4689328.xml">
TNTe</link></definite_quantity>
</unit_of_measurement>
)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;width:5.0em; font-weight:normal;;" class="navbox-group">
Lists</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em; width:auto;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../821/400821.xml">
States with nuclear weapons</link>&nbsp;·  <link xlink:type="simple" xlink:href="../647/2189647.xml">
Nuclear tests</link>&nbsp;·  <link xlink:type="simple" xlink:href="../082/664082.xml">
Nuclear weapons</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../257/37257.xml">
Waste</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em;;;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;width:5.0em; font-weight:normal;;" class="navbox-group">
Disposal</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em; width:auto;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../031/194031.xml">
Fuel cycle</link>&nbsp;·  <link xlink:type="simple" xlink:href="../572/4094572.xml">
Spent fuel</link> (<idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<component wordnetid="105868954" confidence="0.8">
<part wordnetid="105867413" confidence="0.8">
<link xlink:type="simple" xlink:href="../807/2919807.xml">
pool</link></part>
</component>
</concept>
</idea>
&nbsp;&amp;bull;  <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<component wordnetid="105868954" confidence="0.8">
<part wordnetid="105867413" confidence="0.8">
<link xlink:type="simple" xlink:href="../445/363445.xml">
cask</link></part>
</component>
</concept>
</idea>
)&nbsp;·  <artifact wordnetid="100021939" confidence="0.8">
<facility wordnetid="103315023" confidence="0.8">
<depository wordnetid="103177349" confidence="0.8">
<link xlink:type="simple" xlink:href="../807/3885807.xml">
Repository</link></depository>
</facility>
</artifact>
&nbsp;·  <link xlink:type="simple" xlink:href="../845/197845.xml">
Reprocessing</link>&nbsp;·  <link xlink:type="simple" xlink:href="../030/194030.xml">
Transmutation</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;width:5.0em; font-weight:normal;;" class="navbox-group">
Types</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;padding:0.25em 0; line-height:1.4em; width:auto;;;" class="navbox-list navbox-even">
<substance wordnetid="100019613" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../226/3686226.xml">
Reprocessed uranium</link></material>
</part>
</substance>
 &nbsp;&amp;bull;  <link xlink:type="simple" xlink:href="../202/2527202.xml">
Isotopes of plutonium</link>&nbsp;· <substance wordnetid="100019613" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../890/3096890.xml">
Minor actinide</link></material>
</part>
</substance>
&nbsp;·  <link xlink:type="simple" xlink:href="../333/701333.xml">
Fission product</link> (<link xlink:type="simple" xlink:href="../874/15354874.xml">
LLFP</link>)&nbsp;·   <process wordnetid="100029677" confidence="0.8">
<physical_entity wordnetid="100001930" confidence="0.8">
<phenomenon wordnetid="100034213" confidence="0.8">
<substance wordnetid="100019613" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<consequence wordnetid="111410625" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../599/11516599.xml">
Activation product</link></material>
</consequence>
</part>
</substance>
</phenomenon>
</physical_entity>
</process>
</col>
</row>
</table>
</col>
</row>
</table>
</col>
</row>
</table>
</p>



</sec>
</bdy>
</trial>
</article>
